MoneyWorks4Me

Venus Remedies - Quaterly Results

01 Aug 2025 Evaluate
The Revenue for the quarter ended  June 2025 of Rs. 1318.50 millions grew by 24.55 % from Rs. 1058.60 millions.Net Profit witnessed a 162.70% growth almost the double from Rs. 44.50 millions to Rs. 116.90  millions  of same quarter last year.Operating Profit saw a handsome growth to 206.50 millions from 158.40 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1318.50 1058.60 24.55 1318.50 1058.60 24.55 6394.60 5752.10 11.17
Other Income 80.00 15.60 412.82 80.00 15.60 412.82 207.80 113.20 83.57
PBIDT 206.50 158.40 30.37 206.50 158.40 30.37 907.70 722.00 25.72
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 206.50 158.40 30.37 206.50 158.40 30.37 1006.80 722.00 39.45
Depreciation 59.50 57.60 3.30 59.50 57.60 3.30 216.20 255.50 -15.38
PBT 147.00 100.80 45.83 147.00 100.80 45.83 790.60 466.50 69.47
TAX 30.10 56.30 -46.54 30.10 56.30 -46.54 265.10 161.50 64.15
Deferred Tax -6.90 30.90 -122.33 -6.90 30.90 -122.33 46.50 39.30 18.32
PAT 116.90 44.50 162.70 116.90 44.50 162.70 525.50 305.00 72.30
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 15.66 14.96 4.67 15.66 14.96 4.67 14.19 12.55 13.09
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..